Levosimendan in High Risk Patients Undergoing Cardiac Surgery

NCT00994825 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Low Cardiac Output Syndrome

Interventions

DRUG: Levosimendan
DRUG: placebo

Sponsor

Università Vita-Salute San Raffaele